Cargando…
Benefits of the Therapy With Abexol in Patients With Non-Alcoholic Fatty Liver Disease
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of diseases ranging from steatosis to steatohepatitis and cirrhosis. Given the increasing incidence of NAFLD and the long-term consequences of this disease, it is important to identify the risk factors and therapeutic measu...
Autores principales: | Fernandez-Travieso, Julio Cesar, Rodriguez-Perez, Ivan, Ruenes-Domech, Caridad, lIlnait-Ferrer, Jose, Fernandez-Dorta, Lilia, Mendoza-Castano, Sarahi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188363/ https://www.ncbi.nlm.nih.gov/pubmed/32362966 http://dx.doi.org/10.14740/gr1273 |
Ejemplares similares
-
Comparative study of the effects of Abexol and atorvastatin in patients with non-alcoholic fatty liver disease
por: Domech, Caridad Ruenes, et al.
Publicado: (2021) -
Effects of D-002, a mixture of high molecular weight beeswax alcohols, on patients with nonalcoholic fatty liver disease
por: Illnait, José, et al.
Publicado: (2013) -
Evaluation of the effect of D-002, a mixture of beeswax alcohols, on osteoarthritis symptoms
por: Puente, Roberto, et al.
Publicado: (2014) -
Effects of D-003 (10 mg/day) on Bone Mineral Density of the Lumbar Spine and Femoral Neck in Postmenopausal Women: A Randomized, Double-Blinded Study
por: Ceballos, Alfredo, et al.
Publicado: (2011) -
Efficacy and tolerability of Roystonea regia lipid extract (D-004) and terazosin in men with symptomatic benign prostatic hyperplasia: a 6-month study
por: Guzmán, Raúl, et al.
Publicado: (2019)